情绪工作记忆训练对预防抑郁症发生的作用 (CTE 2019)
2026年8月5日 更新者:Wenhui Yang、Hunan Normal University
一项随机、双盲、安慰剂对照评估情绪工作记忆训练在预防抑郁症状中的功效
本研究的目的是检验情绪工作记忆训练和注意力偏差修正训练是否是一种有效的神经行为疗法来预防抑郁症的发生。即情绪工作记忆训练和注意力偏差修正训练在预防抑郁症发生方面是否优于安慰剂。训练后 1 年多的抑郁症。
研究概览
地位
完全的
详细说明
从理论上讲,注意力偏差在抑郁症的发作和维持中起着关键作用。
注意偏差修正训练 (ABMT) 是一种使用训练来诱导适应性注意偏差的实验范式,被开发用于测试因果模型,这对抑郁症具有治疗意义。为了测试 ABMT 对抑郁症状治疗的影响,随机、双盲、安慰剂和空白对照试验在患有轻度至重度抑郁症状的大学生中进行。
研究类型
介入性
注册 (实际的)
110
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。
学习地点
-
-
Hunan
-
Changsha、Hunan、中国、400081
- Department of Psychology, Hunan Normal University
-
-
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
16年 至 21年 (孩子、成人)
接受健康志愿者
不
描述
纳入标准:
- 贝克抑郁量表-II 得分为 14 分或更高。
排除标准:
- 当前发作的重度抑郁症、双相情感障碍、精神分裂症或器质性精神障碍;
- 任何同时进行的心理治疗;
- 任何并发的精神药物。
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:预防
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:三倍
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:positive emotion working memory (PEWM )training
The PEWM task is a computerized n-back task.
The stimulus presents 2000ms.
The longer stimulus duration compared to a standard n-back task is intended to allow participants to more elaboratedly process positive emotion.
During the PEWM, each session has 25-35 minutes.
|
Participants take 10 sessions of positive emotion working memory training with n-bak task of positive words for two-week at itinal and 8 booster sessions at 6 months follow-up.
|
|
实验性的:negative emotion working memory (NEWM) training
The NEWM task was a computerized dual n-back task.
The visual stimulus presents 500 milliseconds (ms), followed by a blank screen for 2500 ms.
The auditory stimulus presents 500-950 ms at the same time.
Participants monitor both modalities.
Each session takes 25-35 minutes.
The first three sessions started with 1 n-level.
From the fourth session , it starts from 2 n-level.
The tasks are adjusted difficulty on the participant's performance.
When accuracy rates equal to or larger than 90% for both the auditory and visual response, participants give an option to advance a n level or keep the same level.
|
Participants take ten 16 × (21 + n) trial sessions of NEWM with dual n-back task with sad facial pictures for visual modality and sad words for auditory modality for 2 weeks at initial and 8 booster sessions for 2 weeks at 6 months follow-up.
|
|
实验性的:Positive attention bias Training (PABT)
The PABT task was a variation of the computerized visual dot-probe task from a previous attention bias modification (ABM) study (Yang, et al., 2015, 2016).
The stimuli present 2000 ms.
The longer stimulus duration compared to a standard dot-probe task was intended to allow participants to have time to more fully process the content of the stimulus.
During the PABT, 27 neutral-positive word pairs were presented 8 times (8 × 27) in each 10-min session.
|
Participants take ten 216-trial sessions of PABT with 90% probe dot fallen on positive words for 2 weeks and eight 216-trial booster sessions for 2 weeks at 6 months follow-up.
|
|
安慰剂比较:placebo (neutral attention bias training, NABT)
The placebo task was identical to the active PABT, except 90% of the probes appeared at the neutral position, 10% at the positive position.During the training, 27 pairs of neutral-positive words are presented 8 times (8 × 27) in each 10-min session.
Participants take ten 216-trial sessions for 2 weeks at inital and 8 booster sessions for 2 weeks at 6 months follow-up.
|
Participants take ten 216-trial sessions of placebo training with 90% probe-dot fallen on neutral concrete words for 2 weeks at initial and 8 booster sessions for 2 weeks at 6 month follow-up.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Onset of a major depressive episode
大体时间:From pre-training to 6 months,12 months. 24 months and 5 years follow-ups after training.
|
Clinicians interviewed the participants using the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children (K-SADS) at initial, 6 months , 12 months and 24 months follow-ups after training and using Structured Clinical Interviews for Diagnostic and Statistical Manual of Mental Disorders, fifth edition ( SCID-5) at 5 years follow-up.
The person has at least 4 depressive symptoms and mild to moderate impairment for a probable episode of major depression, or has 5 or more than 5 symptoms and mild to moderate impairment for a definite episode of major depression.
|
From pre-training to 6 months,12 months. 24 months and 5 years follow-ups after training.
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Self-reported depressive symptoms and clinical significant changes
大体时间:Pre-training, post-training, 2 weeks, 4 weeks, 8 weeks, 12 weeks, 20 weeks, 24weeks, 28weeks, 32 weeks, 12 months, 24 months, and 5 year follow-ups.
|
Self-reported depressive symptoms assessed by Beck Depression Inventory-the second version (BDI-II).
The BDI-II contains 21 questions, each with a score from 0 to 3. The total scores range form 21 to 60.
To evaluate clinical significant changes of depressive symptoms, we follow the procedures outlined by Jacobson and Truax (Jacobson & Truax, 1991) .
A participant is classified as meeting criteria for clinically significant change if (a) the post-training score falls within the range (mean ± 2 SDs) of the nonclinical population on the basis of BDI-II data (Yang, Wu, &Peng, 2012), and (b) if they display a statistically reliable reduction in scores from pre- to post- or to folloow-up assessment based to the reliable change index.
|
Pre-training, post-training, 2 weeks, 4 weeks, 8 weeks, 12 weeks, 20 weeks, 24weeks, 28weeks, 32 weeks, 12 months, 24 months, and 5 year follow-ups.
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 首席研究员:Wenhui Yang, Ph.D、Department of Psychology, Hunan Normal University
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2019年10月15日
初级完成 (实际的)
2025年4月24日
研究完成 (实际的)
2025年5月30日
研究注册日期
首次提交
2020年4月12日
首先提交符合 QC 标准的
2020年4月14日
首次发布 (实际的)
2020年4月15日
研究记录更新
最后更新发布 (实际的)
2026年8月10日
上次提交的符合 QC 标准的更新
2026年8月5日
最后验证
2026年8月1日
更多信息
与本研究相关的术语
其他研究编号
- Cogntive Control EMOTION 2019
- BBA210038 (其他赠款/资助编号:National Social Science Foundation for Chinese Education)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
不
IPD 计划说明
IPD might not be shared due to participant privacy, lack of informed consent, and the risk of misinterpretation or inappropriate secondary analyses
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
不
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.